Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2006-02-21
2006-02-21
Scheiner, Laurie (Department: 1648)
Chemistry: molecular biology and microbiology
Vector, per se
C435S069100, C536S024100, C514S04400A
Reexamination Certificate
active
07001760
ABSTRACT:
The present invention relates to novel hepatitis B virus vectors for use in gene therapy which can deliver therapeutic genes to liver cells. The invention also provides methods for the production of novel recombinant hepatitis B viruses. The recombinant viruses produced by this invention can deliver therapeutic genes specifically to liver cells either through in vivo or ex vivo therapy protocols. This vector can be used not only to treat liver diseases but also genetic diseases.
REFERENCES:
patent: 5744326 (1998-04-01), Ill et al.
patent: 5981274 (1999-11-01), Tyrrell et al.
Anderson, W.,Human Gene Therapy, Science, 256: 808-13 (1992).
Ausubel, F. et al. eds.Current Protocols in Molecular Biology, Wiley and Sons, New York, Suppl. 48 (1995).
Chaisomchit, S. et al.,Development of replicative and nonreplicative hepatitis B virus vectors, Gene Therapy, 4: 1330-40 (1997).
Chiang P. et al.,Characterization of a cis Element Required for Packaging and Replication of the Human Hepatitis B Virus, Virology, 186: 701-11 (1992).
Condreay, L. et al.,Replication of DHBV Genomes with Mutations at the Sites of Initiation of Minus-and Plus-Strand DNA Synthesis, Virology, 188: 208-16 (1992).
Crystal, R.,Transfer of Genes to Humans: Early Lessons and Obstacles to Success, Science, 270: 404-10 (1995).
Douglas, J. et al.,A system for the propagation of adenoviral vectors with genetically modified receptor specificities, Nature Biotechnology, 17: 470-75 (1999).
Friedman T.,The Origins, Evolution, and Directions of Human Gene Therapy, The Development of Human Gene Therapy, Cold Spring Harbor Laboratory Press, NY, (1999).
Galibert, F. et al.,Nucleotide sequence of the hepatitis B virus genome(subtype ayw)cloned in E. coli, Nature, 28: 646-50 (1979).
Ganem, D. et al.,Hepadnaviridae and Their Replication, Fundamental Virology, 3rded., 1199-1233 (1996).
Ganem, D. et al.,The Molecular Biology of The Hepatitis B Viruses, Ann. Rev. Biochem., 56: 651-93 (1987).
Havert, M. et al.,cis-Acting Sequences in Addition to Donor and Acceptor Sites Are Required for Template Switching during Synthesis of Plus-Strand DNA for Duck Hepatitis B Virus, Journal of Virology, 71: 5336-44 (1997).
Hirsh, R. et al.,cis-Acting Sequences Required for Encapsidation of Duck Hepatitis B Virus Pregenomic RNA, Journal of Virology, 65: 3309-16 (1991).
Ho, T., et al.,Effects of Genomic Length on Translocation of Hepatitis B Virus Polymerase-Linked Oligomer, Journal of Virology, 74: 9010-18 (2000).
Jeong, J. et al.Evidence that the 5'-end Cap Structure Is Essential for Encapsidation of Hepatitis B Virus Pregenomic RNA, Journal of Virology, 74: 5502-08 (2000).
Junker-Niepmann, M. et al.,A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA, The EMBO Journal, 9: 3389-96 (1990).
Loeb D. et al.,Mutations within DR2 Independently Reduced the Amount of both Minus- and Plus-Strand DNA Synthesized during Duck Hepatitis B Virus Replication, Journal of Virology, 70: 8684-90 (1996).
Loeb D. et al.,Sequence Identity of the Terminal Redundancies on the Minus-Strand DNA Template Is Necessary but Not Sufficient for the Template Switch during Hepadnavirus Plus-Strand DNA Synthesis, Journal of Virology, 71: 152-60(1997).
Loeb D. et al.,Sequence-independent RNA cleavages generate the primers for plus strand DNA synthesis is hepatitis B viruses: implications for other reverse transcribing elements, The EMBO Journal, 10: 3533-540 (1991).
Loeb D. et al.,Transfer of the Minus Strand of DNA during Hepadnavirus Replication Is Not Invariable but Prefers a Specific Location, Journal of Virology, 69: 6886-891 (1995).
Mulligan, R.,The Basic Science of Gene Therapy, Science, 260: 926-32 (1993).
Nassal, M. et al.,A Bulged Region of the Hepatitis B Virus RNA Encapsidation Signal Contains the Replication Origin for Discontinuous First-Strand DNA Synthesis, Journal of Virology, 70: 2764-73 (1996).
Nassal, M. et al.,Hepatitis B Virus Replication- an update, Journal of Viral Hepatitis, 3: 217-26 (1996).
Nassal, M. et al.,Translational Inactivation of RNA Function: Discrimination against a Subset of Genomic Transcripts during HBV Nucleocapsid Assembly, Cell, 63: 1357-63 (1990).
Pollack, J. et al.,Site Specific RNA Binding by a Hepatitis B Virus Reverse Transcriptase initiates Two Distinct Reactions: RNA Packaging and DNA Synthesis, Journal of Virology, 68: 5579-87.
Protzer, U. et al.,Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection, Proc. Natl. Acad. Sci., 96: 10818-23 (1999).
Sambrook et al.,Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Press 3rded, (2001).
Seeger, C. et al.,Identification of a Signal Necessary for Initiation of Reverse Transcription of the Hepadnavirus Genome, Journal of Virology, 65: 5190-95 (1991).
Sells, M. et al.,Replicative Intermediates of Hepatitis B Virus in HepG2 Cells That Produce Infectious Virions, Journal of Virology, 62: 2836-44 (1988).
Shih, C. et al., In vitropropagation of human hepatitis B virus in a rat hepatoma cell line, Proc. Natl. Acad. Sci., 86: 6323-27 (1989).
Staprans, S. et al.,Mutations Affecting Hepadnvirus Plus-Strand DNA Synthesis Dissociate Primer Cleavage from Translocation and Reveal the Origin of Linear Viral DNA, Journal of Virology, 65: 1255-62 (1991).
Wang, G, et al.,Novel Mechanism for Reverse Transcription in Hepatitis B Virus, Journal of Virology, 67: 6507-12 (1993).
Wang, G. et al.,The Reverse Transcriptase of Hepatitis B Virus Acts As A Protein Primer for Viral DNA Synthesis, Cell, 71: 663-70 (1992).
Yang, Y. et al.,Clearance of Adenovirus-Infected Hepatocytes by MHC Class I-Restricted CD4+CTLsIn Vivo,The Journal of Immunology, 155: 2564-70 (1995).
Yen, T.,Posttranscriptional Regulation of Gene Expression in Hepadnaviruses, Virology, 8: 319-26 (1998).
Cho Woo Young
Jeong Jong Keun
Lee Jehan
Ryu Wang-Shick
Yoon Gye Soon
Reed Smith LLP
Ryu Wang-Schick
Scheiner Laurie
LandOfFree
Hepatitis B virus vectors for gene therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis B virus vectors for gene therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis B virus vectors for gene therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3685336